ECOGEN SIGNS MARKETING PACT WITH URANIAEcogen Inc. of Langhorne, Pa., announced that it has enteredinto an agreement appointing Urania Pflanzenschutz GmbHexclusive distributor for its Condor, Cutlass and Foilbioinsecticides in Germany.

Urania, located in Hamburg, will also support research anddevelopment by Ecogen toward improving and adapting Ecogen'sproducts for use against insect pests throughout Europe.

Under terms of the distribution agreement, Urania will beresponsible for the development, promotion, advertising, saleand service of the Ecogen products throughout Germany, andwill be responsible for government approvals andregistrations.

GLYCOMED UNDERWRITERS PURCHASE OVERALLOTMENT

Glycomed Inc. said Monday that its underwriters, Hambrecht &Quist Inc. and Montgomery Securities, have exercised anoverallotment option to purchase an additional 345,000 sharesof common stock at $7 per share. The Alameda, Calif.-baseddeveloper of carbohydrate-based products for cardiovascularand inflammatory diseases completed its initial publicoffering in June. Glycomed stock (NASDAQ:GLYC) closed at$7.25, down 25 cents, on Monday.

FDA APPROVES IMMUCOR REAGENTS

Immucor Inc. a Norcross, Ga., maker of blood bank reagentsystems, said Monday it has received Food and DrugAdministration approval to manufacture and sell fourmonoclonal blood grouping reagents: anti-A, anti-B, anti-A,Band anti-D. Immucor stock (NASDAQ:BLUD) on Monday rose$1.25, closing at $27.75.

WISCONSIN BUYS CAMBRIDGE NEURO STOCK

The State of Wisconsin Investment Board, an agency that holdsshares in various companies for investment, said Monday thatit has acquired 375,000 shares of Cambridge NeuroScienceResearch Inc. (NASDAQ:CNSI). The shares, acquired betweenJune 6 and June 25 at prices ranging from $8.75 to $12 a share,represent 5.4 percent of Cambridge's shares outstanding.Cambridge completed its initial public offering in June.

The board also raised its stake in MGI Pharma Inc.(NASDAQ:MOGN) to 703,000 shares, or 6.9 percent of sharesoutstanding. The board purchased 170,000 shares on June 25and June 26, paying from $8.13 to $8.25 a share.

EPA APPROVES MOTH PESTICIDE TESTS

Consep Membranes Inc., a Bend, Ore., manufacturer of biologicalpesticides, has received Environmental Protection Agencyapproval to conduct large-scale field trials of CheckMate CMon 3,000 acres in 11 states.

CheckMate uses a natural pheromone, released by femalecodling moths to attract males, in a proprietary dispenser thatpermits controlled release of the chemical. The chemicalconfuses males, who hover around the dispenser until they die.

Codling moths cause millions of dollars in crop damage toapples, pears and walnuts, said Concep spokesman AlanGuggenheim.

Privately held Concep's "ambitious goal is to be on the marketby the 1993 growing season," said Guggenheim. Growers canmarket crops tested in the current field trials.

AGRISTAR, ASGROW TEAM FOR ONION DEVELOPMENT

AgriStar Inc. of Conroe, Texas, said Monday it has entered intoa supply agreement with the Asgrow Seed Co., a subsidiary ofthe Upjohn Co. of Kalamazoo, Mich.

AgriStar will co-develop and Asgrow will commercialize newonion hybrids utilizing a proprietary high-frequency tissueculture technology developed by a research scientist fromTexas A&M University in conjunction with AgriStar'smicropropogation system.

AgriStar said initial laboratory results indicate that thenormal eight- to 10-year process to develop new onionvarieties can be reduced to three years.

(c) 1997 American Health Consultants. All rights reserved.